C3 International, Inc. Email Format

Wellness and Fitness ServicesCalifornia, United States11-50 Employees

C3 International, Inc. is a biopharmaceutical company focused on cannabinoid therapeutics within the wellness and fitness services sector, based in Anaheim, California. Its flagship product, Idrasil, is a natural cannabis formulation delivered as a standardized 25 mg pill intended for pain management, described as a nutraceutical. In California, Idrasil is presented as the only all-natural medical cannabis prescription reimbursable by most health insurers and workers' compensation programs, and the company emphasizes scientific standards and research to support quality of life in medical settings.

The company has populated its Board of Advisors with notable figures, including Ken Shamrock in 2020 and Gary Hall, Jr. in 2019. Idrasil was launched in 2018 as the organization’s flagship pain-management pill, marking an early milestone in its cannabinoid therapeutics program. With a relatively small to mid-sized team, the company operates from Anaheim and concentrates on advancing research-driven approaches within medical and hospital communities.

Sign up for free to view info

Company overview Employee directory